Beatriz Rebollo-Calderon

Beatriz Rebollo-Calderon

Auto-generated profile, based on publicly available information

Beatriz Rebollo-Calderon

Group of Sensors and Biosensors, Department of Chemistry, Autonomous University of Barcelona, Edifici Cn, 08193, Bellaterra, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2022 in Analytica Chimica Acta
Verified
Journal Article
Open access
ACAntonio Calvo-López
Antonio Calvo-López
BRBeatriz Rebollo-Calderon
Beatriz Rebollo-Calderon
AOAida Ormazábal
Aida Ormazábal
RARafael Artuch
Rafael Artuch
JRJavier Rosell-Ferrer
Javier Rosell-Ferrer
MPMar Puyol
Mar Puyol
Some inborn errors of metabolism and other diseases can result in increasing blood ammonium (hyperammonemia episodes), which can cause serious neurological complications in patients or even death. Early diagnosis, follow up and treatment are essential to minimize irreversible damages in brain. Currently, adequate analytical instrumentation for the necessary ammonium bedside determination is not available in all health centers but only in clinical laboratories of reference hospitals. We therefore have developed a low cost and portable potentiometric Point-of-Care microanalyzer (POC) to address this problem. It consists of a cyclic olefin copolymer-based microanalyzer, the size of a credit card and working in continuous flow, which integrates microfluidics, a gas-diffusion module and a potentiometric detection system. The analytical features achieved are a linear range from 30 to 1000 μmol L-1 NH4+, a detection limit of 18 μmol L-1 NH4+ and a required sample volume of 100 μL, which comply with the medical requirements. Plasma and blood samples are analyzed with no significant differences observed between ammonium concentrations obtained with both the proposed microanalyzer and the reference method. This demonstrates the value of the developed POC for bedside clinical applications.